Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 8;7(4):637-42.
doi: 10.1038/nprot.2012.011.

Mouse model of oropharyngeal candidiasis

Affiliations

Mouse model of oropharyngeal candidiasis

Norma V Solis et al. Nat Protoc. .

Abstract

Oropharyngeal candidiasis is a frequent cause of morbidity in patients with defects in cell-mediated immunity or saliva production. Animal models of this infection are important for studying disease pathogenesis and evaluating vaccines and antifungal therapies. Here we describe a simple mouse model of oropharyngeal candidiasis. Mice are rendered susceptible to oral infection by injection with cortisone acetate and then inoculated by placing a swab saturated with Candida albicans sublingually. This process results in a reproducible level of infection, the histopathology of which mimics that of pseudomembranous oropharyngeal candidiasis in humans. By using this model, data are obtained after 5-9 d of work.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histopathology of a typical lesion in the mouse model of oropharyngeal candidiasis after 5 days of infection. The tissue section was stained with periodic acid-Schiff. Scale bar indicates 20 μm.
Figure 2
Figure 2
Image of an anesthetized mouse with a calcium alginate swab placed sublingually.
Figure 3
Figure 3
Time course of oropharyngeal candidiasis. (A) Oral fungal burden of mice with oropharyngeal candidiasis. (B) Effects of infection on body weight. Results are the median ± interquartile range of 8–9 mice per time point.

References

    1. Sangeorzan JA, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994;97:339–346. - PubMed
    1. Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren’s syndrome. J Otolaryngol. 1997;26:300–305. - PubMed
    1. Willis AM, et al. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med. 1999;16:675–679. - PubMed
    1. Redding SW, et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol. 1999;37:3896–3900. - PMC - PubMed
    1. Arribas JR, et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. Aids. 2000;14:979–985. - PubMed

Publication types